Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

1712 with DOI

4 strong · 11 moderate · 2 weak

Compilations

12026-05-03T13:40:34.993Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

32last ruled 2026-06-04

0 awaiting a ruling

Issued documents

62026-10-19T20:31:48.906Z

notice · info card · emergency

Searches

211 with no results

queries and counts on the build

Claims checked

6645 supported

45 supported · 21 not

Correspondence

0received

consent field ships in Phase 4

Edges

219

derivations recorded for this entity

Complete over 17 sources, 1 compilation, and 32 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/escaline/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-10-19issueIssued notice
  4. 2026-09-07srcStructure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors
  5. 2026-09-07srcFluorine in psychedelic phenethylamines
  6. 2026-09-07srcChemistry and Structure-Activity Relationships of Psychedelics.
  7. 2026-09-07srcOpioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects
  8. 2026-09-07srcPharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants
  9. 2026-09-07srcRecent advances in the neuropsychopharmacology of serotonergic hallucinogens
  10. 2026-09-07srcPresent and future of metabolic and metabolomics studies focused on classical psychedelics in humans
  11. 2026-09-07srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
  12. 2026-09-07srcComparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
  13. 2026-09-07srcAcute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects
  14. 2026-09-07srcComparison of the behavioral effects of mescaline analogs using the head twitch response in mice
  15. 2026-09-07srcReceptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines
  16. 2026-09-07srcDifferential phospholipase C activation by phenylalkylamine serotonin 5-HT2A receptor agonists
  17. 2026-09-07srcLipophilicity and serotonin agonist activity in a series of 4-substituted mescaline analogues
  18. 2026-09-07srcDihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives
  19. 2026-09-07srcNCATS Inxight Drugs — ESCALINE
  20. 2026-09-07srcEscaline - Wikipedia
  21. 2026-09-04issueIssued emergency
  22. 2026-09-04issueIssued info_card
  23. 2026-09-04issueIssued notice
  24. 2026-06-04proposal30 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  25. 2026-06-04publicationPublication — backfill
  26. 2026-05-03revisionRevision 1
  27. 2026-05-03absenceSearched ClinicalTrials.gov for "escaline mescaline analog phenethylamine psychedelic" — no results
  28. 2026-05-03genGeneration — pipeline-v5pipeline-v5
  29. 2026-05-03rungeneration run

The same entries, as forms: six forms.